The potential link between Mounjaro and eye twitching may be caused by electrolyte imbalances resulting from gastrointestinal side effects like nausea, vomiting, and diarrhea
In the periphery, GLP-1 acts directly on pancreatic islets to enhance GSIS (Mojsov et al., 1987) and inhibit glucagon release (Komatsu et al., 1989)
Eli Lilly's latest data release follows the company's earlier findings, released in early August, that showed that trial participants who are overweight or have obesity lost an average of 27 pounds or about 12.4% of their body weight after taking Eli Lilly's oral daily GLP-1 pill -- orforglipron -- for at least 72 weeks
Intriguingly, beyond their metabolic benefits, GLP-1RAs also exhibit anti-inflammatory effects
Those who use the treatment period strategically have a fighting chance
Use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and cardiovascular disease: A review